cdmo.directory
← Compare landing

Charles River Cell & Gene Therapy vs Oxford Biomedica

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/criver/oxb

CategoryCharles River Cell & Gene TherapyOxford Biomedica
Listed sitecdmocdmo
SummaryCharles River provides discovery, development, and manufacturing services across the drug development continuum, including cell and gene therapy capabilities.Global viral vector CDMO with 30 years of expertise in lentivirus, AAV, and adenovirus manufacturing. Provides end-to-end development and GMP-compliant manufacturing services from preclinical through commercial launch for cell and gene therapy programs.
Services
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • Technology Transfer
  • Formulation Development
  • Process Development
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • API Synthesis & Manufacturing
  • Upstream Processing
  • Downstream Processing
  • CMC Analytical Development
  • Stability Testing & Storage
  • Cell-Line Development
  • Microbial Fermentation
  • Small Molecule Development & Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • CMC Analytical Development
  • Viral Vector Manufacturing
  • Lentiviral Vector Manufacturing
  • AAV Manufacturing
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Upstream Processing
  • Downstream Processing
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Cell Therapy Manufacturing
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
Indications
  • Oncology
  • Immunology
  • Neurology
  • Oncology
  • Immunology
  • Infectious Disease
Locations
  • Headquarters, United States
  • North America, North America
  • Europe, Europe
  • Asia, Asia
  • Facility, UK, United Kingdom
  • Facility, Europe, France
  • Facility, USA, United States
  • Headquarters, Oxford, Oxfordshire, United Kingdom
  • Oxbox Manufacturing, Oxford, Oxfordshire, United Kingdom
  • Harrow House Manufacturing, Oxford, Oxfordshire, United Kingdom
  • Wallingford Manufacturing, Wallingford, Oxfordshire, United Kingdom
  • Yarnton Manufacturing, Oxford, Oxfordshire, United Kingdom
  • Bedford Manufacturing, Bedford, Massachusetts, United States
  • Durham Manufacturing, Durham, North Carolina, United States
  • Lyon Manufacturing, Lyon, Auvergne-Rhône-Alpes, France
  • Strasbourg Manufacturing, Illkirch-Graffenstaden, Grand Est, France
  • EU Support Office, Dublin, Dublin, Ireland
  • Chancery Gate Manufacturing, Oxford, Oxfordshire, United Kingdom
  • Yarnton Manufacturing, Yarnton, Oxfordshire, United Kingdom
  • US Facility, United States, United States
  • European Facility, France, France
Certifications
  • FDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: Retrogenix® platform data support
  • PMDA · Identifier: Retrogenix® platform data support
  • FDA · Identifier: Drug Master File (DMF)
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.